N ESFATIN-1, a recently discovered satiety molecule, is distributed in several brain areas implicated in the feeding and metabolic regulation, including the hypothalamic paraventricular nucleus (PVN), supraoptic nucleus (SON), arcuate nucleus, lateral hypothalamic area, and nucleus tractus solitarius in the brain stem (1-4). Intracerebroventricular (icv) administration of nesfatin-1 and NEFA/ nucleobinding-2 (NUCB2), a precursor of nesfatin-1, suppresses food intake, whereas icv administration of antinesfatin-1 antibody increases food intake (1). Nesfatin-1 suppresses feeding in a leptin-independent manner; nesfatin-1 antibody did not inhibit leptin-induced satiety and nesfatin-1 suppresses food intake in Zucker rats whose leptin receptor is mutated (1).
N ESFATIN-1, a recently discovered satiety molecule, is distributed in several brain areas implicated in the feeding and metabolic regulation, including the hypothalamic paraventricular nucleus (PVN), supraoptic nucleus (SON), arcuate nucleus, lateral hypothalamic area, and nucleus tractus solitarius in the brain stem (1) (2) (3) (4) . Intracerebroventricular (icv) administration of nesfatin-1 and NEFA/ nucleobinding-2 (NUCB2), a precursor of nesfatin-1, suppresses food intake, whereas icv administration of antinesfatin-1 antibody increases food intake (1) . Nesfatin-1 suppresses feeding in a leptin-independent manner; nesfatin-1 antibody did not inhibit leptin-induced satiety and nesfatin-1 suppresses food intake in Zucker rats whose leptin receptor is mutated (1) .
Both NUCB2 mRNA level and nesfatin-1 concentration in the PVN significantly decrease after 24 h starvation as compared with ad libitum (1) . This suggests that nesfatin-1 in the PVN could play a role in satiety and, possibly, energy homeostasis after meal intake. In the PVN, several distinct endogenous peptides (CRH, oxytocin, TRH, and vasopressin) inhibit food intake (5) (6) (7) (8) . In the PVN and SON, nesfatin-1-immunoreactive neurons were colocalized with oxytocin and vasopressin (2) . Therefore, possible interaction between the neurons containing these neuropeptides and nesfatin-1 neurons in the PVN and SON could be implicated in the regulation of feeding and metabolism. In this study, therefore, we investigated colocalization of nesfatin-1 with classical neuropeptides of the PVN and SON and explored the regulation of nesfatin-1 neurons by refeeding.
Materials and Methods Animals
Adult (7-9 wk old) male Sprague Dawley rats were maintained on a 12-h light, 12-h dark cycle and given conventional food (CE-2; Clea, Osaka, Japan) and water ad libitum. The animal protocols for this study were approved by the Jichi Medical University Institute of Animal Care and Use Committee and were in accordance with the Japanese Physiological Society's guidelines for animal care.
Tissue preparation for immunohistochemistry
Rats were deeply anesthetized with urethane (1 g/kg, ip) and were perfused transcardially with saline containing heparin (20 U/ml) for 3 min and then 4% paraformaldehyde in 0.1 m phosphate buffer (PB) for 20 min. The brains were removed and postfixed in the same fixative for 1 h and in 4% paraformaldehyde in 0.1 m PB containing 15% sucrose overnight at 4 C. They were then transferred to 30% sucrose solution in 0.1 m PB for 2 d. The brains were frozen on dry ice and kept at Ϫ80 C until sectioning. Coronal sections (40 m) of the hypothalamus were cut using a freezing microtome and collected at 160-m intervals.
For the immunohistochemistry of TRH and CRH, rats received an icv injection of colchicine before perfusion. One day before perfusion, rats were anesthetized by injection of Avertin (tribromoethanol, 200 mg/kg, ip) and placed in a stereotaxic frame (DAVID Kopf Instruments, Tujunga, CA), and a stainless steel guide cannula (26-gauge) was inserted into the brain with the tip in the right lateral ventricle; 0.8 mm caudal and 1.6 mm right to the bregma and 3.5 mm below the skull, and then colchicine (0.2 mg/15 l/animal dissolved in saline) was injected into the lateral ventricle through a 30-gauge injection needle.
Triple-labeling immunohistochemistry for nesfatin-1, oxytocin, and vasopressin
Sections were rinsed in PBS (0.01 m PB and 0.9% NaCl) and then blocked with 1% BSA, 1% normal goat serum and 0.1% Triton X-100 in PBS for 1 h. Then they were incubated with first antibodies, rabbit anti-nesfatin-1 antibody (Gunma University; 1:1000) (1), mouse antioxytocin monoclonal antibody (MAB5296; Chemicon, Temecula, CA; 1:600), and guinea pig anti-Arg8-vasopressin antiserum (T-5048; Peninsula Laboratories, San Carlos, CA; 1:2000), diluted in blocking solution for overnight at room temperature (RT). After rinsing, sections were incubated with secondary antibodies, Alexa 488 goat antirabbit IgG, Alexa 350 goat antimouse IgG, and Alexa 594 goat anti-guinea pig IgG (Molecular Probes, Carlsbad, CA; 1:500) for 40 min. Slices were then rinsed, mounted on slides, and coverslipped with fluorescent mounting medium (DakoCytomation, Carpinteria, CA). Before performing the triple-and double-labeling immunohistochemistry, each primary antibody was tested separately, and immunohistochemical control included omission of primary antibodies in each case. Fluorescence images were acquired with a BX50 microscope and a DP50 digital camera (Olympus, Tokyo, Japan). Using Photoshop (Adobe, San Jose, CA), brightness and contrast were adjusted, and fluorescence photographs were combined to visualize double-or triple-labeled cells by the screen blending mode. To count fluorescence, one combined photograph from each 40-m slice was used.
Double-labeling immunohistochemistry for nesfatin-1 and TRH or CRH
For double-labeling immunohistochemistry for nesfatin-1 and TRH or CRH, we used anti-nesfatin-1, anti-TRH, and anti-CRH antiserums raised in rabbits. To eliminate the possible cross-reactivity, a modification of recently described protocol was used (9, 10) . Briefly, the sections were rinsed and then blocked. Sections were incubated with a rabbit primary antiserum against nesfatin-1 (1:100,000) or TRH (11170; Progen Biotechnik, Heidelberg, Germany; 1:5,000) overnight at RT. Sections were rinsed and incubated with biotinylated goat antirabbit IgG (Vector Laboratories, Burlingame, CA; 1:500) for 30 min and were incubated with ABC reagent (Vector Laboratories; 1:500) for 30 min. Then sections were rinsed in buffer of 0.1 m Tris-HCl (pH 7.5), 0.15 m NaCl, and 0.05% Tween 20 and blocked with 0.05% blocking reagent (PerkinElmer, Waltham, MA). Then sections were treated with biotinyl tyramide (PerkinElmer 1:50) diluted in amplification reagent (PerkinElmer) for 5 min. After rinse in buffer of 0.1 m Tris-HCl (pH 7.5), 0.15 m NaCl, and 0.05% Tween 20, sections were incubated with streptavidin-Alexa 488 conjugate (Molecular Probes; 1:500) diluted in blocking reagent for 40 min. After a rinse in PBS, sections were incubated with a primary rabbit antiserum against CRH (T-4037; Peninsula Laboratories; 1:1000) or nesfatin-1 (1:1000) overnight, rinsed, and incubated with Alexa 594 goatantirabbit IgG (Molecular Probes; 1:500) for 40 min. After treatment with first primary antibodies against nesfatin-1 (1:100,000) or TRH (1:5,000), the treatment with Alexa 594 goat-antirabbit IgG resulted in no staining.
Acquirement of confocal images
Double-labeling immunohistochemistry for nesfatin-1 and oxytocin was done by following the procedure. Sections were blocked and incubated with rabbit anti-nesfatin-1 antibody and mouse antioxytocin monoclonal antibody as first antibodies, as described above. Then sections were incubated with secondary antibodies, Alexa 488 goat antirabbit IgG, and Alexa 594 goat antimouse IgG (Molecular Probes; 1:500) for 40 min. The other double-labeling immunohistochemistries were done by the same procedure as described above. Confocal fluorescence images were acquired with a confocal laser-scanning microscope (Fluoview FV300-TP; Olympus).
Double-labeling immunohistochemistry for c-Fos and nesfatin-1 in ad libitum-fed, fasted, and refed rats
For the study under fasting and refeeding conditions, food deprivation for 48 h was followed by 2 h refeeding that started at the beginning of the dark phase. Two hours after the beginning of the dark phase, rats were anesthetized and fixed, and brain sections were prepared as described. Sections were rinsed in PBS and then incubated in 0.3% H 2 O 2 for 20 min. After rinsing, sections were blocked for 30 min and incubated with rabbit anti-c-Fos antibody (Ab-5; Calbiochem, San Diego, CA; 1:100,000) overnight at RT. Then the sections were rinsed and incubated with biotinylated goat antirabbit IgG for 30 min. After the rinse, sections were incubated with ABC reagent for 30 min (Vector Laboratories; 1:500). After the rinse in PBS and 0.175 m sodium acetate buffer (pH 5.6), color was developed with a nickel-diaminobenzidine (DAB) solution (10 g/liter nickel ammonium sulfate, 0.2 g/liter DAB, and 0.006% H 2 O 2 in sodium acetate buffer) for 5 min.
After the rinse in PBS, sections were treated with an avidin and biotin blocking solution (Vector Laboratories) and then incubated with rabbit anti-nesfain-1 antibody (1:5000) diluted in a blocking solution overnight at RT. After the rinse, sections were incubated with biotinylated goat antirabbit antibody for 30 min and incubated in ABC reagent for 30 min. Then the sections were rinsed in PBS and Tris-buffered saline [0.1 m Tris-HCl (pH 7.4), 0.15 m NaCl], and color was developed with a DAB solution (0.2 g/liter DAB and 0.006% H 2 O 2 in Tris-buffered saline). Slices were then rinsed, mounted on slides, and coverslipped with Entellan new (Merck, Darmstadt, Germany).
Real-time RT-PCR analysis
Two hours after the beginning of the dark phase, rats were deeply anesthetized with urethane and decapitated, and their brains were removed. Brain slices containing the entire SON were prepared, and the entire SON was excised from the left and right sides. Total RNA of SON was isolated using TRIzol (Invitrogen, Carlsbad, CA) and treated with RQ1-DNase (Promega, Madison, WI) to remove residual contaminations with DNA. First-strand cDNA synthesis was completed using ReverTra Ace (Toyobo, Osaka, Japan). Primers for real-time PCR were first examined by HotStarTaq DNA polymerase (94 C for 15 sec, 60 C for 20 sec, and 72 C for 20 sec ϫ 30 cycles; QIAGEN, Hilden, Germany) and agarose gel electrophoresis for correct product size and absence of primer-dimer formation. Using a QuantiTect SYBR Green PCR kit (QIAGEN), realtime PCRs (95 C for 15 sec, 60 C for 20 sec, and 72 C for 20 sec ϫ 40 cycles) were performed in an ABI-Prism 7700 sequence detector (Applied Biosystems, Foster City, CA). Product accumulation was measured in real time, and the mean cycle threshold (the cycle during which the product is first detected) was determined for replicate samples (n ϭ 8 or 9 independent reactions per primer pair and cDNA sample) run on the same plate. Different cDNA samples were normalized using primer sets to the housekeeping gene glyceraldehydes-3-phosphate dehydrogenase. Primers were as follows: glyceraldehydes-3-phosphate dehydrogenase, 5Ј-GGCACAGTCAAGGCTGAGAATG-3Ј and 5Ј-ATGGTGGTGAA-GACGCCAGTA-3Ј; NUCB2, 5Ј-TGGAAACAGATCCGCATTTCAG-3Ј and 5Ј-CAGTTCATCCAGTCTCGTCCTCAC-3Ј.
Data presentation and statistical analysis
Data are presented as the mean Ϯ se. Each study was based on at least three rats. Data were analyzed by one-way ANOVA and differences were evaluated by Fisher's protected least significant difference. Values of P Ͻ 0.05 were considered significant.
Results

Nesfatin-1 neurons were colocalized with oxytocin, vasopressin, CRH, and TRH neurons in the PVN
In the PVN, nesfatin-1, oxytocin, and vasopressin-immunoreactive neurons were identified by Alexa 488 (green), 350 (blue), and 594 (red) fluorescence, respectively (Fig. 1, A-C) . Total 534.5 Ϯ 136.7 (n ϭ 4) nesfatin-1-immunoreactive neurons were found in PVN, in which 127.0 Ϯ 30.5 (n ϭ 4) (24%) neurons were oxytocin-immunoreactive (light blue and white), 95.0 Ϯ 19.0 (n ϭ 4) (18%) were vasopressin-immunoreactive (yellow and white), and 42.0 Ϯ 10.2 (n ϭ 4) (8%) were both oxytocin and vasopressin immunoreactive (white) (Fig. 1) . Conversely, 127.0 Ϯ 30.5 of 318.0 Ϯ 42.4 (n ϭ 4) (40%) oxytocin-immunoreactive neurons were nesfatin-1-immuno-reactive, and 95.0 Ϯ 19.0 of 201.5 Ϯ 22.0 (47%) (n ϭ 4) vasopressin-immunoreactive neurons were nesfatin-1 immunoreactive. Furthermore, confocal analysis detected the colocalization of nesfatin-1 with oxytocin and vasopressin in the PVN with higher resolution (Fig. 2, A-C and G-I) .
We also investigated the colocalization of nesfatin-1 with CRH or with TRH in the neurons of the PVN. Nesfatin-1 neurons were identified by Alexa 488 fluorescence (green) and CRH neurons by Alexa 594 fluorescence (red) (Fig. 1, E  and F) . Total 431.4 Ϯ 76.6 (n ϭ 3) nesfatin-1-immunoreactive neurons were found in PVN, in which 54.7 Ϯ 16.8 (n ϭ 3; 13%) neurons were CRH immunoreactive (yellow) (Fig. 1G) . Conversely, 54.7 Ϯ 16.8 of 412.2 Ϯ 39.0 (n ϭ 3; 13%) CRHimmunoreactive neurons were nesfatin-1 immunoreactive.
Furthermore, confocal analysis revealed fine colocalization of nesfatin-1 and CRH (Fig. 2, M-O) . Next, nesfatin-1 neurons were identified by Alexa 594 fluorescence (red), and TRH neurons by Alexa 488 fluorescence (green) (Fig. 1, H neurons were found in PVN, in which 59.1 Ϯ 16.5 (n ϭ 3; 12%) neurons were TRH immunoreactive (yellow) (Fig. 1J) . Conversely, 59.1 Ϯ 16.5 of 219.1 Ϯ 76.9 (27%; n ϭ 3) TRHimmunoreactive neurons were nesfatin-1 immunoreactive. Colocalization of nesfatin-1 and TRH was confirmed in confocal images (Fig. 2, P-R) .
Nesfatin-1 neurons were colocalized with oxytocin and vasopressin neurons in the SON
In the SON, the nesfatin-1, oxytocin, and vasopressinimmunoreactive neurons were identified by Alexa 488 (green), 350 (blue), and 594 (red) fluorescence, respectively (Fig. 3, A-C) . Total 440.0 Ϯ 71.2 (n ϭ 4) nesfatin-1-immunoreactive neurons were found in SON, in which 153.5 Ϯ 32.1 (n ϭ 4; 35%) neurons were oxytocin immunoreactive (light blue and white), 124.5 Ϯ 28.8 (n ϭ 4; 28%) were vasopressin immunoreactive (yellow and white), and 25.3 Ϯ 6.1 (n ϭ 4; 6%) were immunoreactive to both oxytocin and vasopressin (white) (Fig. 3D) . Conversely, 153.5 Ϯ 32.1 of 310.3 Ϯ 25.9 (n ϭ 4; 49%) oxytocin-immunoreactive neurons and 124.5 Ϯ 28.8 of 210.0 Ϯ 30.7 (n ϭ 4; 59%) vasopressin-immunoreactive neurons were nesfatin-1 immunoreactive. Confocal analysis detected fine colocalization of nesfatin-1 with oxytocin and vasopressin in the SON (Fig. 2, D-F 
and J-L).
Refeeding induced c-Fos expression in nesfatin-1 neurons of the PVN and SON
After refeeding for 2 h following 48 h fasting, c-Fos-immunoreactive neurons were observed abundantly in the SON, PVN, dorsomedial hypothalamic nucleus, and preoptic area and to a lesser extent in the arcuate nucleus of the hypothalamus. In the PVN, c-Fos immunoreactivity was observed in 90.7 Ϯ 24.7 (n ϭ 3) nesfatin-1-immunoreactive neurons in ad libitum conditions, 22.0 Ϯ 7.0 (n ϭ 5) neurons in fasting conditions, and 211.4 Ϯ 56.3 (n ϭ 5) neurons in refeeding conditions (Fig. 4, A-E) . The number of nesfatin-1 neurons expressing c-Fos immunoreactivity was significantly (10 times, P Ͻ 0.005) greater under refeeding, compared with fasting conditions (Fig. 4E) .
In the SON, c-Fos-immunoreactivity was observed in 155.7 Ϯ 34.9 (n ϭ 3) nesfatin-1-immunoreactive neurons in ad libitum conditions, 26.0 Ϯ 21.5 (n ϭ 5) neurons in fasting conditions, and 799.8 Ϯ 162.5 (n ϭ 5) neurons in refeeding conditions (Fig. 5, A-E) . Thus, the number of c-Fos-positive nesfatin-1 neurons was dramatically elevated by refeeding, compared with ad libitum (5 times, P Ͻ 0.005) and fasting conditions (31 times, P Ͻ 0.0005) (Fig. 5E ). Total number of nesfatin-1 immunoreactive neurons in the SON was significantly increased by refeeding (1443.0 Ϯ 174.5 neurons, n ϭ 5), compared with ad libitum (865.3 Ϯ 87.9 neurons, n ϭ 5, P Ͻ 0.05) and fasting conditions (538.4 Ϯ 70.4 neurons, n ϭ 5, P Ͻ 0.0005) (Fig. 5F ). Relative ratios of NUCB2 mRNA expression in the SON were significantly decreased (P Ͻ 0.005) in fasting (0.144 Ϯ 0.013, n ϭ 9), compared with ad libitum (0.503 Ϯ 0.110, n ϭ 8), and increased (P Ͻ 0.05) by refeeding (0.361 Ϯ 0.064, n ϭ 9), compared with fasting (Fig. 5G ).
Discussion
In this study, we found that nesfatin-1 neurons are abundant in the PVN and SON and that they overlap extensively with oxytocin and vasopressin neurons and, to a lesser extent, with CRH and TRH neurons. Our finding not only confirmed the recent report (2) but also substantiated the observation by quantitative analysis. Refeeding after fasting dramatically increased the number of nesfatin-1 neurons that express c-Fos immunoreactivity in the PVN and SON. In the SON, refeeding also increased the number of nesfatin-1-immunoreactive neurons and mRNA expression of NUCB2. These findings suggest that nesfatin-1 neurons in the PVN and SON, possibly via interaction with oxytocin and vasopressin neurons, may play a role in the postprandial regulation of the feeding behavior and peripheral metabolism.
It has recently been reported that nesfatin-1 is colocalized with oxytocin and vasopressin in the PVN (2) . In this study, we quantified the colocalization of nesfatin-1 with oxytocin, vasopressin, CRH, and TRH in the PVN. Among these neuropeptides, CRH is thought to be implicated in anorexia nervosa and the feeding suppression under stress conditions (11) . Therefore, the specific subtype of nesfatin-1 neuron that coexpresses CRH in the PVN could be involved in the potent anorectic effect of nesfatin-1. However, the incidence of this subtype of nesfatin-1 neuron is modest (13%). In contrast, as much as 24% of the PVN nesfatin-1 neurons coexpress oxytocin. Furthermore, 40% of the PVN oxytocin neurons contain nesfatin-1. The finding that nesfatin-1 and oxytocin neurons highly overlap in the PVN might imply possible functional association between nesfatin-1 and oxytocin. It has been reported that the parvocellular PVN oxytocin neurons project to the nucleus tractus solitarius, the site at which central and peripheral signals are integrated, and that this neuronal pathway is related to inhibition of food intake (12, 13) . Collectively, the PVN nesfatin-1/oxytocin neurons could also be involved in the anorectic nesfatin-1 pathway.
It was previously reported that an icv injection of ␣-MSH increases NUCB2 mRNA expression in the PVN, suggesting that nesfatin-1 neurons in the PVN could function downstream of melanocortin pathway (1). However, underlying mechanisms have remained unknown. We found that nesfatin-1 in the PVN is colocalized with oxytocin, vasopressin, CRH, and TRH, the substances that are thought to work at downstream of melanocortin pathway: central administration of ␣-MSH activates oxytocin, CRH, and TRH neurons (13) (14) (15) and stimulates vasopressin release in PVN (16) . Melanocortin-4 receptors, the principal receptor that mediates anorectic effects of ␣-MSH, are distributed abundantly in the PVN (17, 18) . The melanocortin-4 receptors located in the PVN are important for the feeding regulation (19) . Collectively, we speculate that the PVN nesfatin-1-neurons coexpressing oxytocin, vasopressin, CRH, or TRH could serve as an effector of melanocortin signaling.
It was shown that the refeeding-induced c-Fos expression in the ventral parvocellular subdivision of PVN depends on melanocortin signal (20) . Hence, our results could be interpreted that refeeding influenced proopiomelanocortin neurons, which in turn evoked c-Fos in nesfatin-1 neurons. Neuromedin U (NMU) could also be upstream of nesfatin-1 because an icv injection of NMU increases c-Fos expression in the SON and PVN (21, 22) , and NMU induces satiety in a leptin-independent manner similarly to nesfatin-1 (23) .
Refeeding (24) and scheduled food intake (25) increase c-Fos expression in the SON and PVN. We not only confirmed this previous report but also identified a novel neuron subtype as the target: refeeding markedly stimulates c-Fos expression in nesfatin-1-immunoreactive neurons in the SON and PVN. In the SON, furthermore, c-Fos-expression occurs primarily in nesfatin-1-immunoreactive neurons. It was shown that the c-Fos expressing neurons in the SON after refeeding are mainly vasopressin neurons (24) . Therefore, it is likely that at least a fraction of c-Fos-expressing nesfatin-1 neurons in the SON, observed in the present study, coexpresses vasopressin. Although physiological roles of the nesfatin-1 neurons coexpressing vasopressin remain unknown, it could be related to the metabolic effects of vasopressin: peripheral injection of vasopressin suppresses food intake (8) , and vasopressin-1a receptor knockout mice exhibit abnormalities in lipid metabolism (26) , glucose homeostasis (27) , and blood pressure (28) . In the PVN, refeeding induces c-Fos expression in not only magnocellular neurons containing vasopressin neurons but also parvocellular neurons containing CRH neurons (24) . Parvocellular nesfatin-1 neurons could also be related to the postrefeeding functions.
It should be noted that, although our protocol of 48 h fasting and 2 h refeeding has been used widely as the condition of hunger and satiety, the additional and/or complex physiological effects cannot be excluded. Stress can be induced by food deprivation (29) , and icv administration of stress-related hormones, NMU, induces c-Fos expression in the PVN and SON (21, 22) . Therefore, the c-Fos induction in nesfatin-1 neurons could underlie stress-related functions other than feeding. Furthermore, the PVN and SON are implicated in the homeostasis of water balance (30) , a function that can secondarily influence food intake (31) .
In this study, the amount of NUCB2 mRNA expression and the number of nesfatin-1-immunoreactive neurons also changed on fasting and refeeding. It is reported that the mRNA expression of NUCB2 in the pancreatic islets increases more than 5 times in the high-fat diet-fed mice, compared with normal diet conditions (32) . Hence, acute and chronic metabolic states may affect the expression of NUCB2 mRNA and nesfatin-1.
This study demonstrated that nesfatin-1 neurons in the PVN and SON overlap extensively with oxytocin and vasopressin neurons and that refeeding highly selectively activates nesfatin-1 neurons in the PVN and SON and increases nesfatin-1 expression in the SON. These findings suggest a hypothesis that nesfatin-1 neurons in the PVN and SON play a role in the postprandial regulation of feeding and energy homeostasis. To verify this hypothesis, functional interaction of nesfatin-1 with oxytocin, vasopressin, and other neuropeptides in the PVN and SON needs to be clarified.
